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ABSTRACT
Background and the purpose of the study: The success of any direct-tableting procedure is strongly 
affected by the quality of the crystals used in the process. Ibuprofen is a poorly compactible drug 
with a high tendency for capping. In order to use ibuprofen in direct compression formulations, 
physico-mechanical properties of ibuprofen should be improved considerably. The aim of the 
present investigation was to employ crystallization techniques in order to improve the physico-
mechanical properties of ibuprofen for direct compression.
Methods: The experimental methods involved the preparation of ibuprofen crystals by solvent 
change technique. Ibuprofen was dissolved in ethanol and crystallized out with water in the 
absence or presence of various hydrophilic additives (PEG 6000, 8000, Brij 98P and polyvinyl 
alcohol 22000, PVA 22000) with different concentrations. The physico-mechanical properties of 
the ibuprofen crystals were studied in terms of flow, density, tensile strength and dissolution 
behaviour. Morphology of ibuprofen crystals was studied by scanning electron microscopic 
(SEM). Solid state of the recrystallized particles was also investigated using differential scanning 
calorimeter (DSC) and FT-IR.
Results: Ibuprofen samples crystallized in the presence of PEG 6000 and 8000 and PVA showed 
remarkable increase in the tensile strengths of the directly compressed tablets, while some 
other additives, i.e. Brij 98P did not produce improved ibuprofen crystals. Ibuprofen powders 
made from particles obtained in the presence of PVA and Brij 98P showed similar dissolution 
profiles to the commercial ibuprofen particles. DSC and FT-IR results ruled out any significant 
interaction between ibuprofen and additives except for the samples crystallized in the presence 
of PEG 8000.
Conclusion: The crystal habit of ibuprofen can be altered successfully by the crystallization 
technique which was developed in this study. The crystals developed in the presence of certain 
additives can be recommended for direct compression.
Keywords: Crystallization, Ibuprofen, Crystal habit, Additives, Tensile strength, Dissolution, 
Solid state
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INTRODUCTION
Crystallization is a major technological process for 
particle formation in the pharmaceutical industry. 
Many drug substances form different crystal lattices 
with different internal packing arrangements of 
molecules; thus polymorphic forms exist. However, 
there are also drugs whose crystals only have 
differences in their outer appearance; these drugs 
form different habits without differences in the 
crystal lattice (crystal habit). The crystal habit of 
a drug is an important variable in pharmaceutical 
manufacturing. Different crystal forms of a particular 
drug possess different planes and thus differ not 
only in their specific surface, but also in their free 
surface energy. Therefore, they may exhibit different 
physico-mechanical properties (1). It has been 
shown that properties such as dissolution 
rate, powder flow, and compressibility, which 
are of pharmaceutical interest, can differ for 
different habits of the same drug (2-5). For example, 
acetaminophen can exist in two polymorphic forms, 
the common crystal form is the thermodynamically 
stable form I (monoclinic) which leads to unstable 
tablets with high capping tendency due to a stiff 
construction of the molecules inside the crystal and 
form II (orthorhombic) that shows better compaction 
behaviour (6). 
Ibuprofen a common analgesic drug with 
antipyretic action is widely administered orally 
and topically (7). It is also used in the relief of 
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symptoms of rheumatoid arthritis and osteoarthritis 
(8). Because of its hydrophobic properties, it 
shows low solubility in water. Ibuprofen shows 
poor compressibility and compactibility under 
compaction process and most of the tablets 
produced at high speed were capped (9), thus in 
most cases for production of solid dosage forms a 
granulation step is necessary. Ibuprofen can form 
different crystal forms with different properties. 
It has been shown that the type of solvent and the 
presence of a methacrylic polymer had remarkable 
effect on the crystal habit of ibuprofen prepared by 
a temperature change method (10). Crystallization 
was carried out with different cooling rates using 
different alcohols with acetone in the presence of 
different methacrylic polymers. They showed that 
the solvent and the cooling rate had an effect on 
the micromeritic properties due to interactions with 
hydrophobic faces of the growing crystals, but the 
polymer had a smaller effect (10). The polarity of 
the solvent affects the crystal habit, as the use of 
methanol resulted in the most symmetrical crystals 
while the use of a low polarity solvent (acetone) 
resulted in elongated crystals. A further study (11) 
described differences in crystal habit of ibuprofen 
crystallized by a cooling process from different 
alcohols and hexane. During the cooling process 
ibuprofen powder was added as nuclei. While 
ibuprofen crystallized from methanol and ethanol 
shows a polyhedral crystal habit, crystallization 
from hexane resulted in needle-like crystals. 
Lee et al (12) used different solvents to crystallize 
ibuprofen and acetaminophen and showed that in 
order to have a successful scale up preparation, a full 
knowledge of solubility, polymorphism, crystal habit 
and crystallinity of solid compounds is necessary, 
however they did not study the effect of the type of 
solvent on mechanical behaviour and dissolution of 
ibuprofen powders. Similar study was carried out by 
Gavrilin et al., showed the solubility of ibuprofen 
was affected by the type of crystal habit (13). The 
work published by Di Martino was mainly about 
densification mechanism of ibuprofen crystallized 
from different organic solvents (14). The effect of 
various additives on micromeritic, dissolution and 
mechanical behaviours of crystallized ibuprofen 
powders has not been described previously.  
Ibuprofen is presently being crystallized in the 
commercial scale from hexane and heptan into 
a crystal that has a poor flow and compaction 
properties owing to its needle-like crystalline and 
viscoelastic property (15, 16) which creates great 
difficulties in direct compression formulations. 
Therefore the aim of the present investigation 
was to explore a suitable solvent and additive for 
crystallization of ibuprofen in order to improve 
its physic-mechanical properties for direct 
compression purpose without any negative effect 
on its dissolution performance.
MATERIALS AND METHODS
Ibuprofen (Spectrum, USA), ethanol (Fisher, UK), 
Polyethylene glycol (PEG) with molecular weight 
of 6000 and 8000 (Acros Organics, USA), Brij 98P 
(Sigma-Aldrich, USA) and polyvinyl alcohol (PVA) 
with molecular weight of 22000 (Acros Organics, 
USA) were used in this investigation.
Scanning electron microscope (SEM)
The shape and surface topography of crystallized 
and commercial ibuprofen crystals were determined 
by using scanning electron microscope (LEO 440I, 
Cambridge, UK) operating at 15 kV. The specimens 
were mounted on a metal stub with double-sided 
adhesive tape and coated under vacuum with gold in 
an argon atmosphere prior to observation. 
Differential scanning calorimetery (DSC)
Samples of the crystals (about 5 mg) were heated (30-
120 ºC) at a scanning rate of 10 ºC/min in crimped 
hemetically-sealed aluminium pans under a nitrogen 
atmosphere. The enthalpy of fusion and melting 
point could be obtained from the thermograms using 
the instrumental software (DSC 822 Mettler Toledo, 
Switzerland). The calorimeter was calibrated using 
indium and lead standards.
Fourier transforms infrared spectroscopy (FT-IR)
A computerized FT-IR (PerkinElmer, USA) was 
used to obtain the spectrum of various ibuprofen 
samples. The crystal sample (about 10 mg) was 
placed on the plate of the machine and the handle 
was placed on powder sample to generate enough 
pressure for compression. The spectrum for each 
sample showed the wavelength of absorbed light 
which is a characteristic of the chemical bonds in 
the sample. The scanning range was 600-4000 cm-1 
and the resolution was 1 cm-1.
Compressibility index measurement 
Flowability of untreated and agglomerated samples 
was also assessed from Carr’s Index (CI) (17, 18). 
The CI was calculated from the poured and tapped 
densities. Tapped density was determined by tapping 
the samples (10 g) into a 10 ml measuring cylinder 
using a tapping machine. The CI was calculated 
according to the following equation.  
CI = [(Tapped density-Bulk density) / Tapped density] 
×100    
 Pressure-tensile strength relationship
The ibuprofen particles (100 ± 5 mg) were compressed 
using a 6 mm flat-faced punch at a constant 
compression speed with different compaction 
pressures (50, 100 and 150 MPa), using a hydraulic 
press (Minipress, TP3, Copley, UK). Lubrication of 
the die and punch was performed using a 1% w/v 
dispersion of magnesium stearate in acetone. The 
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compacts were allowed to relax for 24 hrs and the 
force fracturing the compact (F) was measured. The 
tensile strength (T) of the compact was calculated 
according to the following equation (19). 
T=2F/ (πDt)
where D and t are the diameter and thickness 
of the compact, respectively. The results are the 
mean and standard deviations of a minimum of 5 
determinations. 
Dissolution test
The ibuprofen powder (100 ± 10 mg) was filled 
into capsules without any additional excipient. 
Dissolution was performed (Erweka DT700, 
Germany) in 900 ml of phosphate buffer of pH 7.2 
at 50 rpm and 37±0.1oC using the rotating paddle 
method. Samples of the solution were withdrawn at 
pre-determined time intervals (3, 6, 9, 12, 15, 20, 25, 
30, 40, 50 and 60 min) using peristaltic pump attached 
to the dissolution tester. The amount of dissolved 
ibuprofen was analyzed spectrophotometrically 
(UV-160, Shimadzu, Japan) at 221 nm.
 RESULTS AND DISCUSSION
Micromeritic and morphology studies of ibuprofen 
crystals
It has already been shown that the crystal habit of 
ibuprofen depends on crystallization conditions such 
as the type of solvent and the presence of additives 
(11, , 16, 20-22). SEM of various recrsytallized 
ibuprofen samples are shown in figure 1. The figure 
shows that the commercial ibuprofen is needle-
like shaped, whereas the samples recrysallized 
in the presence of additives showed plate-like 
(figure 1c) or irregular shape (figures 1b and e). 
When crystallization was carried in the presence of 
PEG 6000, agglomerated particles were observed 
(figure 1d). As a result of the different crystal 
morphology, the prepared ibuprofen crystals might 
show significant differences in the micromeritic and 
mechanical properties. Micormeritic behaviours 
of the commercial ibuprofen and all engineered 
ibuprofen particles are listed in table 1. It is obvious 
from Carr’s index values that the flow of commercial 
ibuprofen is extremely poor due to a high cohesivity 
and adhesivity. Because of poor flowability and 
compactibility of the commercial ibuprofen powder, 
in most cases the drug has to be granulated before 
tableting. The micrormeritic properties of ibuprofen 
can be improved by choosing a suitable crystal 
form (a suitable crystal habit). Table 1 shows that 
all engineered ibuprofen powders showed lower 
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Figure1.  Scanning electron micrographs of (a) untreated, and treated ibuprofen 
powders in: (b) absence of additives, (c) presence of 5% PEG 8000, (d) presence of 
5% PEG 6000, (e) presence of 5% PVA22000 . 
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Figure 1. Scanning electron micrographs of (a) untreated, and 
treated ibuprofen powders in: (b) absence of additives, (c) pres-
ence of 5% PEG 8000, (d) presence of 5% PEG 6000, (e) pres-
ence of 5% PVA22000 .
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Carr’s index than the commercial ibuprofen powder 
which is an indication of an improvement in flow 
behaviour of ibuprofen powder. The increase in 
powder flow of engineered particles could be partly 
due to an increase in true density of ibuprofen 
powders (Table 1). Table 1 also shows the bulk 
density data of various ibuprofen samples. The table 
shows that, in general, the best flow is obtained for 
the samples with high bulk density. The samples 
with bulk density above 0.35 g/cm3 showed better 
flowability than the samples that their bulk densities 
are smaller than 0.35 g/cm3. The differences in the 
bulk density of various ibuprofen samples may be 
related to their markedly different crystal habits, 
leading to different contact points and frictional and 
cohesive forces between the crystals. These factors 
in turns affect the sliding of the particles against 
each other, leading to different packing geometry 
and hence different bulk densities. These data are 
in good agreement with morphology of ibuprofen 
crystals (Figure 1) since the commercial ibuprofen 
shows needle-like crystals hence low bulk density 
and low flowability. The study showed that the 
presence of additive in the crystallization medium 
can improve flow of ibuprofen powders. Similar 
results has been reported by Rasenack and Muller 
(22), showing that when ibuprofen is crystallized 
in the presence of hydrophilic additives such as 
sucrose, an improvement in flow of powder is 
achieved. As it is shown in figure 1 ibuprofen which 
crsytallized in the presence of additives showed 
different crystal shapes and in the case of samples 
which were recrystallized in the presence of PEG 
6000 some agglomerations were observed. Rasenack 
and Muller (22) also showed that ibuprofen particles 
can be agglomerated if it is recrystallized from 
acetonitrile and methanol. In another study they 
showed that the shape of crystals can be modified 
when ibuprofen was crystallized in the presence of 
various hydrophilic additives (16). The properties of 
the additives such as interaction with the dissolved 
ibuprofen might be the main factor that influences 
the direction in which crystals grow on the nuclei. 
Therefore, the formation of different crystal shapes in 
the presence of different additives may be attributed 
to the interactions of these additives with ibuprofen.
 
Mechanical properties of crystallized ibuprofen 
samples
Compactibility or tabletability, which is the 
capacity of a powdered material to be transformed 
into a tablet of a specific strength under the effect 
of compaction pressure (24) are presented in figures 
2-5.  In these figures the tensile strength of all tablets 
made from various ibuprofen crystals obtained in 
the presence of various additives with different 
concentrations were plotted against compaction 
pressure. Two-way analysis of variance showed 
that with exception of tablets made from ibuprofen 
crystals obtained in the presence of Brij 98P, the 
type of additives and compression pressure had 
significant effect on tensile strength of tablets made 
from ibuprofen crystals (Figure 4). It is obvious from 
all these figures that tablets made from engineered 
ibuprofen crystals in most cases showed superior 
compactibility than the commercial ibuprofen 
crystals. In the case of ibuprofen recrystallized in 
the presence of various concentration of PEG 8000, 
all recrystallized samples showed higher tensile 
strength than untreated ibuprofen. Similar results 
may be drawn for those samples recrystallized in 
the presence of PEG 6000 (Figure 3) and PVP22000 
(Figure 5). However in the case of Brij 98P only 
the recrystallized ibuprofen in the absence of 
additive showed higher tensile strength than 
untreated ibuprofen (Figure 4). In other words, 
Sample True density (g/cm3) Bulk density (g/cm3) Carr’s Index (%)
Commercial ibuprofen 1.085±0.027 0.25±0.03 45.0±2.5
Engineered ibuprofen without additive 1.110±0.003 0.38±0.03 26.3±2.2
Engineered Ibu. 1%PEG 8000 1.132±0.002 0.36±0.05 27.8±3.6
Engineered Ibu. 2%PEG 8000 1.222±0.008 0.52±0.03 27.5±2.5
Engineered Ibu. 5%PEG 8000 1.139±0.015 0.35±0.02 23.8±1.8
Engineered Ibu. 1%PEG 6000 1.161±0.005 0.29±0.06 24.4±2.2
Engineered Ibu. 2%PEG 6000 1.158±0.003 0.38±0.04 27.5±2.6
Engineered Ibu. 5%PEG 6000 1.1430.004 0.39±0.04 28.9±3.1
Engineered Ibu. 1% Brij 98P 1.148±0.005 0.28±0.02 34.9±3.2
Engineered Ibu. 2% Brij 98P 1.150±0.003 0.32±0.04 34.2±3.0
Engineered Ibu. 5% Brij 98P 1.146±0.001 0.36±0.02 27.9±1.7
Engineered Ibu. 1% PVA22000 1.014±0.006 0.30±0.06 40.0±4.3
Engineered Ibu. 2% PVA22000 1.259±0.019 0.24±0.05 32.5±3.1
Engineered Ibu. 5% PVA22000 1.185±0.005 0.25±0.02 33.3±1.9
Table 1. Micromeritic properties of various ibuprofen crystals (the results are the mean and standard deviations of 3 determinations).
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ibuprofen recrystallized in the presence of various 
concentrations of Brij 98P showed weaker tablets 
than the commercial ibuprofen tablets. To compare 
the effect of various additives with the same 
concentration on ibuprofen tablets figure 6 was 
constructed. The figure shows that ibuprofen tablets 
made of recrystallized drug in the presence of PVA 
showed superior tensile strength than other additives. 
This indicates that the effect of additives on tensile 
strength of ibuprofen tablets can be ranked as PVA 
> PEG6000 = PEG 8000 > Brij 98P. The results 
showed that when the molecular weight of PEG was 
increased from 6000 to 8000, no significant changes 
(p > 0.05) were observed for the tensile of ibuprofen 
tablets (Figure 6).  The poor compactibility of drug 
crystals may be attributed to the presence of crystal 
faces that give poor adhesion to other crystals and 
the absence of the faces that are required for optimal 
adhesion (24). The poor compactibility of crystals 
could partly be due to morphology of ibuprofen 
crystals (Figure 1).  It has been shown that in the 
case of ibuprofen needle-like and grain-like crystals 
the relative abundance of the different faces within 
the crystals was modified (11). This can affect the 
inter-particulate bonding between these crystals, 
resulting in different compaction properties. Figure 
6 also showed that the concentration of additive 
used in the crystallization process of ibuprofen 
had no remarkable effect on the tensile strength of 
ibuprofen tablets. 
Figure 2. The effect of compaction pressure on tablets made from engineered ibuprofen particles in the presence of PEG 8000 (the results 
are the mean and standard deviations of 6 determinations).
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Dissolution study
Ibuprofen is poorly water soluble drug and belongs to 
class II drug. Therefore an increase in the dissolution 
rate of ibuprofen should increase its bioavailability. 
The dissolution profiles of ibuprofen crystallized in 
the presence of various additives shown in figure 
7 reveals that samples crystallized in the absence 
of additive and in the presence of 5% w/v PEG 
8000 and PEG 6000 showed poorer dissolution 
performance than the commercial ibuprofen. On the 
other hands, ibuprofen samples crystallized in the 
presence of Brij 98P and PVA22000 showed better or 
the same performance as untreated ibuprofen. The 
results showed that the concentration of additives in 
the crystallization medium had no significant effect 
on ibuprofen dissolution, so, these figures were not 
included in the present study. In summary, it may be 
concluded that PVA is the best additive to be added to 
ibuprofen crystallization medium to produce robust 
tablet with at least similar dissolution performance 
as untreated ibuprofen samples.    
Solid state studies
DSC was used to investigate any change in the type 
of polymorph during the crystallization between 
additives and ibuprofen. The DSC thermograms of 
untreated ibuprofen and all ibuprofen crystallized 
in the presence of various additives are shown in 
Figure 4. The effect of compaction pressure on tablets made from engineered ibuprofen particles in the presence of Brij 98P (the results 
are the mean and standard deviations of 6 determinations).
Figure 5. The effect of compaction pressure on tablets made from engineered ibuprofen particles in the presence of PVA22000 (the results 
are the mean and standard deviations of 6 determinations).
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figure 8. Since all thermograms were similar, only 
the thermograms of the samples crystallized in the 
presence of 5% additive are shown. The enthalpy 
and melting point of all samples are reported in 
table 2. The results showed that the commercial tab 
ibuprofen had a sharp endothermic peak around 
79 °C indicating the fusion of ibuprofen at this 
temperature with an enthalpy of 128.75 J/g. The 
thermogram of recrystallized ibuprofen without 
any additive is similar to the commercial ibuprofen 
with a small reduction in the fusion point. The 
statistical test showed that the reduction in the 
fusion and enthalpy are not significantly different 
compared to the commercial sample (P > 0.05). 
This indicates that the crystallization of ibuprofen 
from ethanol had no significant effect on ibuprofen 
polymorph. The thermograms of ibuprofen samples 
crystallized in the presence of different PEGs 
showed two endothermic peaks related to the fusion 
of PEG and melting of ibuprofen respectively. This 
indicates that PEG molecules might be entrapped 
or adsorbed to the ibuprofen crystals during the 
crystallization process. It is clear from the table 
that as more PEG was added to the crystallization 
medium the enthalpy of ibuprofen peak decreased 
which could be due to the presence of more PEG 
molecules adsorbed to ibuprofen samples at high 
concentration of additives. Another reason for the 
21
Figure 6. The effect of additive concentration on tensile strength from ibuprofen 
tablets made of various engineered particles (the results are the mean and standard 
deviations of 6 determinations). 
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Figure 7. Dissolution behaviour of various ibuprofen crystals (the results are the mean 
and standard deviations of 3 determinations). 
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reduced enthalpy of ibuprofen peak could be due to 
the dissolution of ibuprofen particles in the melted 
PEG during the heating. These could be the main 
reasons why ibuprofen melting point is slightly 
shifted to lower temperatures for samples. All these 
data indicate that no polymorphic modification 
23
Figure 8. Scanning electron micrographs of (a) untreated, and treated ibuprofen 
powders in: (b) absence of additives, (c) presence of 5% PEG 8000, (d) presence of 
5% PEG 6000, (e) in the presence of 5% Brij 98P, (f) presence of 5% PVA22000.
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Figure 9. FT-IR spectra of (a) untreated, and treated ibuprofen powders in: (b) 
absence from additives, (c) presence of 5% PEG 8000, (d) in presence of 5% PEG 
6000, (e) presence of 5% Brij 98P, (f) presence of 5% PVA22000 . 
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Figure 9. FT-IR spectra of (a) untreated, and treated ibuprofen powders in: (b) absence from additives, (c) presence of 5% PEG 8000, (d) 
in presence of 5% PEG 6000, (e) presence of 5% Brij 98P, (f) presence of 5% PVA22000 .
occurred during the crystallization of ibuprofen 
particles.
Further analysis was carried out by FT-IR to identify 
any changes in molecular level. The FT-IR spectra of 
ibuprofen showed characteristic peaks at 1710 cm-1 
and  2920 cm-1 due to carbonyl and hydroxyl stretching 
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respectively (Figure 9). These characteristic peaks 
appeared in all FT-IR spectra of crystallized ibuprofen 
samples indicating no changes in molecular level of 
ibuprofen when it is recrystallized in the presence of 
additives. However, in the case of the sample which 
was crystallized in the presence of PEG 8000, the 
peak at 1710 cm-1 was shifted to higher wave number 
indicating interaction between ibuprofen and PEG 
8000. Such an interaction did not occur for ibuprofen 
samples obtained in the presence of PEG 6000. 
CONCLUSION
Crystal habit of ibuprofen was successfully modified 
by crystallization of the drug in the presence of 
various hydrophilic additives. The results showed 
that the crystal habit modification of ibuprofen 
improves the flow of powder and also mechanical 
behaviour of ibuprofen tablets without any negative 
effect on its dissolution performance. The crystals 
which developed in the presence of certain additives 
can be recommended for direct compression.
Sample Melting point (ºC) Enthalpy (J/g)
Commercial ibuprofen 78.46±1.62 128.75±1.0
Engineered ibuprofen without additive 79.18±1.37 126.55±1.3
Engineered Ibu. 1%PEG 8000 77.10±1.21 95.4±2.5
Engineered Ibu. 2%PEG 8000 76.95±1.15 90.2±2.1
Engineered Ibu. 5%PEG 8000 76.45±1.11 83.3±1.2
Engineered Ibu. 1%PEG 6000 77.95±1.90 108.1±2.6
Engineered Ibu. 2%PEG 6000 77.56±1.84 100.1±2.4
Engineered Ibu. 5%PEG 6000 77.48±1.50 88.0±1.9
Engineered Ibu. 1% Brij 98P 78.20±1.24 119.4±2.5
Engineered Ibu. 2% Brij 98P 78.02±1.20 115.2±3.1
Engineered Ibu. 5% Brij 98P 78.00±0.80 107.1±2.1
Engineered Ibu. 1% PVA22000 78.40±1.33 129.1±1.9
Engineered Ibu. 2% PVA22000 78.45±1.9 127.2±1.6
Engineered Ibu. 5% PVA22000 79.68±1.86 124.5±2.9
Table 2. Thermal behaviour of various ibuprofen samples (the results are the mean and standard deviations of 3 determinations).
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